期刊文献+

甲型血友病基因携带者检出及产前诊断研究 被引量:1

Hemophilia A gene carriers detection and prenatal diagnosis
原文传递
导出
摘要 目的探讨甲型血友病(hemophilia A,HA)型血友病基因携带者检出及产前诊断的准确性和诊断率。方法 12个HA家系66名成员和2名胎儿,采集外周血或脐血,采用FⅧ基因第13内含子的(CA)n重复多态性、第18内含子内Bcl-1位点和第22内含子内Xba-1位点的多态性连锁分析进行间接基因诊断和产前基因诊断。结果 12个HA家系筛查成功率为100%,12个HA家系中41名女性成员,其中27例确定为HA致病基因携带者,14名排除携带状态;对其中2个家系的2名胎儿进行产前诊断,1例诊断为血友病基因携带者,1例诊断为血友病患儿,建议终止妊娠。结论联合采用上述3个多态位点可对HA家系作出快速、准确的基因诊断和产前基因诊断。 Objective To explore the detection of hemophilia A(HA)gene carriers,prenatal diagnosis accuracy and diagnostic rate.Methods Totally 66 family members and 2 fetuses from 12 HA pedigrees were collected peripheral blood or cord blood.The(CA)n repeat polymorphism in the 13 th intron in FⅧ gene,polymorphism linkage analysis restriction Bcl-1 site in the 18 th intron and Xba-1 restriction site in the 22 th intron were adopted to conduct indirect gene diagnosis and prenatal gene diagnosis.Results The genetic scanning rate was 100% in 12 HA pedigrees.There were 41 female members in 12 HA pedigrees,in which 27 were identified as carriers of HA disease genes,and 14 were not the carriers.Two fetuses from 2HA pedigrees received prenatal diagnosis,in which one fetus was diagnosed with carrier of hemophilia gene and the other was diagnosed with hemophilia and was suggested to terminate pregnancy.Conclusion The combined use of the above three polymorphic sites can make a fast and accurate genetic diagnosis as well as prenatal genetic diagnosis for HA pedigree.
出处 《中华实用诊断与治疗杂志》 2016年第4期352-354,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 广东省深圳市科技局资助项目(JH200507120880A)
关键词 甲型血友病 基因诊断 连锁分析 Hemophilia A genetic diagnosis linkage analysis
  • 相关文献

参考文献10

二级参考文献77

  • 1黄淑帧,周霞娣,盛敏,朱皓,任兆瑞,曾溢滔.应用DNA体外扩增技术对血友病A进行产前诊断[J].遗传与疾病,1989,6(3):129-131. 被引量:4
  • 2陈建辉.羊水细胞、脐血细胞ABO血型PCR-SSP法基因定型与血清学定型比较[J].中国输血杂志,2006,19(4):285-287. 被引量:2
  • 3Trossaert M, Boisseau P, Quemener A, et al. Prevalence, biolog- ical phenotype and genotype in moderate/mild hemophilia A with discrepancy between one-stage and chromogenic factor Ⅷ activity. J Thromb Haemost, 2010, 9:524-530.
  • 4Jochen G, Hans-Hermann B, Johannes O, et al. Haemophilia A: from mutation analysis to new therapies. Nat Rev Genet, 2005,6 : 488-501.
  • 5Keeney S, Mitchell M, Goodeve A. The molecular analysis of hae- mophilia A : a guideline from the UK haemophilia centre doctors' organization haemophilia genetics labora-tory network. Haemophilia, 2005, 11:387-397.
  • 6Baguall RD, Waseem N, Green PM, et al. Recurrent inversion breaking intron 1 of the factor V1 gene is a frequent cause of severe hemophilia A. Blood, 2002, 99:168-174.
  • 7Pipe SW, Saenko EL, Eickhorst AN, et al. Hemophilia A muta- tions associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicatedAdomains of thrombin-activated factor Ⅷa. Blood, 2001, 97: 685-691.
  • 8Tizzano EF, Sofia JM, Coil I, et al. The prothrombin 20210A al- lele influences clinical manifestations of hemophilia A in patients with intron 22 inversion and without inhibitors. Haematologica, 2002, 87:279-285.
  • 9Lee DH, Walker IR, Teitel J, et al. Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia A. Thromb Haemost, 2000, 83:387-389.
  • 10Arbini AA, Mannucci PM, Bauer KA. Low prevalence of the factor V Leiden mutation among " severe" hemophiliacs with a "milder" bleeding diathesis. Thromb Haemost, 1995,74 : 1255- 1258.

共引文献16

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部